CMND
Price
$0.99
Change
+$0.01 (+1.02%)
Updated
Apr 24, 02:17 PM (EDT)
Capitalization
5.13M
CYTOF
Price
$0.07
Change
-$0.00 (-0.00%)
Updated
Apr 23 closing price
Capitalization
264.5K
Ad is loading...

CMND vs CYTOF

Header iconCMND vs CYTOF Comparison
Open Charts CMND vs CYTOFBanner chart's image
Clearmind Medicine
Price$0.99
Change+$0.01 (+1.02%)
Volume$1K
Capitalization5.13M
Altamira Therapeutics
Price$0.07
Change-$0.00 (-0.00%)
Volume$702
Capitalization264.5K
CMND vs CYTOF Comparison Chart
Loading...
CMND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CMND vs. CYTOF commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMND is a Buy and CYTOF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (CMND: $0.98 vs. CYTOF: $0.07)
Brand notoriety: CMND and CYTOF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMND: 33% vs. CYTOF: 4%
Market capitalization -- CMND: $5.13M vs. CYTOF: $264.5K
CMND [@Biotechnology] is valued at $5.13M. CYTOF’s [@Biotechnology] market capitalization is $264.5K. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMND’s FA Score shows that 1 FA rating(s) are green whileCYTOF’s FA Score has 1 green FA rating(s).

  • CMND’s FA Score: 1 green, 4 red.
  • CYTOF’s FA Score: 1 green, 4 red.
According to our system of comparison, CMND is a better buy in the long-term than CYTOF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMND’s TA Score shows that 5 TA indicator(s) are bullish.

  • CMND’s TA Score: 5 bullish, 3 bearish.

Price Growth

CMND (@Biotechnology) experienced а +0.66% price change this week, while CYTOF (@Biotechnology) price change was +6.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.04%. For the same industry, the average monthly price growth was -8.89%, and the average quarterly price growth was -12.57%.

Reported Earning Dates

CMND is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (+8.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CMND($5.14M) has a higher market cap than CYTOF($264K). CMND has higher P/E ratio than CYTOF: CMND (0.17) vs CYTOF (0.04). CMND YTD gains are higher at: -29.246 vs. CYTOF (-36.652).
CMNDCYTOFCMND / CYTOF
Capitalization5.14M264K1,945%
EBITDA-4.65MN/A-
Gain YTD-29.246-36.65280%
P/E Ratio0.170.04436%
Revenue0N/A-
Total Cash5.92MN/A-
Total Debt46KN/A-
FUNDAMENTALS RATINGS
CYTOF: Fundamental Ratings
CYTOF
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CMND
RSI
ODDS (%)
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
77%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Ad is loading...
CMND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PAR57.411.57
+2.81%
PAR Technology Corp
ASO37.590.71
+1.93%
Academy Sports and Outdoors
CBNK28.410.25
+0.89%
Capital Bancorp
XFOR0.20N/A
-0.84%
X4 Pharmaceuticals
SU35.08-0.34
-0.96%
Suncor Energy

CMND and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMND has been loosely correlated with CYTOF. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CMND jumps, then CYTOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMND
1D Price
Change %
CMND100%
-2.36%
CYTOF - CMND
41%
Loosely correlated
-1.41%
SLRN - CMND
38%
Loosely correlated
-3.85%
CDT - CMND
32%
Poorly correlated
-4.22%
HURA - CMND
32%
Poorly correlated
+2.57%
NEUP - CMND
30%
Poorly correlated
+1.19%
More

CYTOF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTOF has been loosely correlated with CMND. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTOF jumps, then CMND could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTOF
1D Price
Change %
CYTOF100%
-1.41%
CMND - CYTOF
56%
Loosely correlated
-2.36%
COGT - CYTOF
40%
Loosely correlated
+3.00%
SPHDF - CYTOF
35%
Loosely correlated
+6.61%
LOGC - CYTOF
32%
Poorly correlated
+1.23%
UBX - CYTOF
29%
Poorly correlated
+0.51%
More